Janssen, Bayer Say It Is Time To End Fluoroquinolone MDL

( October 10, 2024, 10:54 AM EDT) -- MINNEAPOLIS — The Janssen and Bayer defendants named in the fluoroquinolone multidistrict litigation asked the court to terminate the MDL, arguing that the MDL “has fulfilled its original purpose and that maintaining the MDL no longer promotes the just and efficient conduct of litigation.”...

Attached Documents

Related Sections